All Clinical Trials

Clinical Trial

AALL1331, Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

  • Recruiting participants (Starts Jan. 19, 2015)
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: Tamra Lynn Slone

summary

See protocol/CiRB application

eligibility

See protocol

If you are interested in this clinical trial, please contact Lindsay Therrian on the Children’s Health Research Team.Call 214-645-7094Email